首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1736849

2026 年至 2032 年聚合酵素鏈鎖反應(PCR) 市場（按產品、應用、最終用戶和地區）

Polymerase Chain Reaction PCR Market By Product (Instruments, Reagents & Consumables), Application (Clinical Diagnostics, Life Sciences), End User (Clinical Diagnostics Labs, Research Institutions, Pharmaceutical Companies), & Region for 2026-2032

出版日期: 2025年05月07日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

聚合酵素鏈鎖反應（PCR）市場 2026-2032

感染疾病負擔的增加、個人化醫療革命、基因組研究和癌症診斷的蓬勃發展以及醫療保健領域的監測因此，感染疾病負擔的增加、個性化醫療革命、基因組研究和癌症診斷的蓬勃發展以及醫療保健領域的監測將成倍地推動市場規模的成長，到 2024 年將超過 109.5 億美元，到 2032 年達到 203.2 億美元的估值。

隨著法醫學的進步，開發中國家和小型產業正日益普及，因為它們能夠從微小的犯罪現場樣本中進行DNA分析。因此，法醫學的進步在新興國家日益普及，推動市場在2026年至2032年間的複合年成長率達到6.50%。

聚合酵素鏈鎖反應（PCR）市場：定義/概述

聚合酵素鏈鎖反應(PCR) 被認為是一項突破性技術，它能夠從微小的 DNA 樣本中產生數百萬個拷貝，就像放大海灘上的一粒沙子一樣。 PCR 不僅可以檢測每一粒沙子，還能產生數百萬個相同的拷貝，以便進行全面的分析。

PCR 過程涉及一系列嚴格控制的步驟。首先，分離目標 DNA，加熱將雙螺旋結構分離成單鏈。然後引入引子（設計用於匹配目標區域起始和終止位置的特定 DNA 片段）。之後，使用一種稱為 DNA聚合酵素的酵素。

對快速診斷測試的需求不斷成長以及 PCR 技術的日益普及將如何影響聚合酵素鏈鎖反應(PCR) 市場的成長？

快速診斷檢測需求的不斷成長以及PCR技術的日益普及是聚合酵素鏈鎖反應(PCR)市場成長的主要原因。 PCR技術因其高準確度、自動化、精密度、即時定量和高靈敏度等特點，正日益廣泛採用。 qPCR技術能夠提供廣泛的核酸輸入，使其成為一項實用且極具價值的研究應用技術。它在腫瘤學和遺傳疾病研究、幹細胞研究、病原體檢測、感染疾病研究、藥物基因組學、藥物分析、農業生物技術和植物科學研究等領域有著廣泛的應用。此外，它在法醫學領域也得到了廣泛的應用。

阿茲海默症、透納氏症、帕金森氏症等慢性病、感染疾病疾病和遺傳疾病的發生率不斷上升。此外，先天性心臟疾病患者的數量正在增加，需要醫療專業人員使用分子診斷工具進行準確診斷。由於不健康飲食、肥胖、大量菸酒消費和久坐的生活方式，癌症發病率預計會增加。據世界衛生組織歐洲區域主任稱，在冠狀病毒感染患者中，每 10 例死亡病例中就有 8 例是患有心血管疾病/高血壓、糖尿病和其他慢性潛在疾病的患者。 SARS-CoV-2 大流行推動了對 qPCR 儀器和耗材的需求。預計 COVID-19 發病率的上升將導致預防性篩檢激增，從而推動市場成長。

新興國家QPCR設備的高成本將如何阻礙聚合酵素鏈鎖反應（PCR）市場的成長？

qPCR 儀器的高成本阻礙了聚合酵素鏈鎖反應(PCR) 市場的成長。據報導，Bio-Rad Laboratories 的 CFX Connect PCR 檢測系統售價約為 17,995 美元。相較之下，賽默飛世爾科技的 7,900 HT qPCR 系統售價為 2 萬至 3 萬美元。數位 PCR 儀器以其更精準的結果和更高的靈敏度而聞名，其價格高於即時PCR儀器。手動 dPCR 儀器的價格估計為 6.5 萬至 7 萬美元，而自動化 dPCR 儀器的價格則接近 10 萬美元。

此外，樣本製備或 PCR 過程中的污染已得到公認，可能導致假陽性結果，這在各種應用中，尤其是在診斷環境中，可能產生重大影響。污染源多種多樣，包括環境 DNA、樣本間的交叉污染以及先前 PCR 反應的殘留物。要緩解這些問題，需要實施完善的方案、聘用訓練有素的人員並持續進行品管措施。這些措施包括使用專用 PCR 工作站、對設備進行紫外線消毒以及在每次 PCR 運行中設定陰性對照。

The increase in infectious disease burden, personalized medicine revolution, genomics research boom & cancer diagnostics and monitoring in the healthcare sector. Thus, the growing infectious disease burden, personalized medicine revolution, genomics research boom & cancer diagnostics, and monitoring in the healthcare sector surge the growth of market size surpassing USD 10.95 Billion in 2024 to reach the valuation of USD 17.32 Billion by 2032.

Forensic science advancements are becoming more and more popular in developing countries and small-scale industries due to DNA profiling from minuscule crime scene samples. Thus, forensic science advancements are gaining popularity in emerging countries enabling the market to grow at a CAGR of 6.50% from 2026 to 2032.

Polymerase Chain Reaction PCR Market: Definition/ Overview

The Polymerase Chain Reaction (PCR) is considered a groundbreaking technique by which millions of copies can be generated from a minuscule DNA sample. An analogy can be drawn to magnifying a single grain of sand on a beach. Through PCR, not only can that individual grain be scrutinized, but millions of identical replicas can also be produced, enabling comprehensive analysis.

A series of meticulously controlled steps is involved in the PCR process. Initially, the target DNA is isolated and subjected to heat, causing the double helix to be separated into single strands. Primers, which are specific DNA fragments designed to match the target region's beginning and end, are then introduced. Subsequently, an enzyme known as DNA polymerase is employed.

How do the Increasing Demand for Rapid Diagnostic Tests and Growing Adoption of PCR Technologies have any Implications for the Growth of the Polymerase Chain Reaction PCR Market?

The increase in demand for rapid diagnostic tests and the growing adoption of PCR technologies are the dominant reasons for the growth of the polymerase chain reaction PCR market. PCR techniques are being increasingly adopted due to their accuracy, automation, precision, real-time quantification, and sensitivity. A wide range of input nucleic acids is offered by qPCR, making it a practical and valuable technology in research applications. Diverse applications are found in areas such as oncology & genetic disease research, stem cell research, pathogen detection, research of infectious diseases, pharmacogenomics, pharmaceutical analytics, agricultural biotechnology, and plant sciences research. It is also significantly used in forensic sciences.

The increase in the prevalence of chronic & infectious diseases and genetic disorders, such as Alzheimer's disease, Turner syndrome, & Parkinson's disease. Furthermore, the number of patients with congenital heart disease is increasing, necessitating the use of molecular diagnostic tools by medical professionals for accurate diagnoses. Cancer prevalence is expected to be increased by unhealthy dietary habits, obesity, high tobacco & alcohol consumption, and a sedentary lifestyle. According to WHO Regional Director for Europe, 8 out of 10 deaths in coronavirus-infected patients were suffered by those with cardiovascular diseases/hypertension, diabetes, and other chronic underlying conditions. The demand for qPCR equipment and consumables is being driven by the SARS-CoV-2 pandemic. A surge in preventive screenings is expected to be prompted by the increasing incidence of COVID-19, facilitating market growth.

How Does the High QPCR Device Costs in Emerging Countries Impede the Growth of the Polymerase Chain Reaction PCR Market?

The high QPCR device costs hinder the growth of the polymerase chain reaction PCR market. It is reported that the CFX Connect PCR Detection System by Bio-Rad Laboratories is priced at approximately USD 17,995. In comparison, Thermo Fisher Scientific's 7900 HT qPCR system is found to be priced between USD 20,000 and USD 30,000. Digital PCR instruments, which are known for more accurate results and sensitivity, are priced higher than real-time PCR instruments. The cost of a manual dPCR instrument is estimated to be between USD 65,000 and USD 70,000, while automated dPCR instruments can be priced at nearly USD 100,000.

Furthermore, it has been recognized that contamination during sample preparation or the PCR process can lead to false positive results, which can have significant implications in various applications, particularly in diagnostic settings. The sources of contamination are diverse and can include environmental DNA, cross-contamination between samples, or carryover from previous PCR reactions. It is understood that mitigating these issues requires the implementation of robust protocols, the employment of well-trained personnel, and the maintenance of ongoing quality control measures. These measures may include the use of dedicated PCR workstations, UV sterilization of equipment, and the inclusion of negative controls in each PCR run.

Category-Wise Acumens

How Do the Well-Surface Characteristics, And Material Properties Foster the Growth of the Consumables & Reagents Segment?

The consumable & reagents segment dominates in the polymerase chain reaction market. The well-surface characteristics of PCR consumables are being recognized as a critical factor in the segment's growth. It is understood that the surface properties of the wells can significantly impact the efficiency of DNA amplification. Surfaces that are optimized for DNA binding and release are being developed, which is contributing to improved PCR results. Furthermore, it has been noted that different surface treatments are being applied to enhance the compatibility of consumables with various sample types and PCR chemistries.

Material properties of PCR consumables are also being identified as a key driver of the segment's expansion. It is being reported that manufacturers are focusing on developing materials that offer superior heat conductivity and thermal stability. These properties are essential for ensuring rapid and uniform temperature changes during PCR cycles. Furthermore, materials that minimize evaporation and prevent sample loss are being increasingly adopted, which is leading to more consistent and reliable results.

How Do the Disciplines of Personalized Medicine and Genomics Research in the Healthcare Sector Surge the Growth of the Clinical Diagnostics Segment?

The clinical diagnostic segment dominates the polymerase chain reaction market. The growth of the clinical diagnostics segment is being significantly propelled by the rapidly evolving disciplines of personalized medicine and genomics research in the healthcare sector. It is observed that PCR techniques are being increasingly relied upon for crucial activities such as gene analysis and variation detection within these fields. As advancements are made in personalized medicine and genomics, a corresponding surge in the demand for PCR applications is being witnessed in the life sciences sector. The role of PCR in routine diagnostics is being further solidified by the rising burden of infectious diseases, which is contributing to its increased adoption. While both clinical diagnostics and life sciences applications are expected to make substantial contributions to market growth, it is anticipated that clinical diagnostics may hold a slight advantage in the near term due to its established position in routine testing protocols. However, it is projected that the life sciences segment has the potential to emerge as the dominant application in the long run, driven by its association with cutting-edge research and progress in personalized care approaches.

Country/Region-wise Acumens

How the Well-developed Healthcare System Surges the Growth of the Polymerase Chain Reaction PCR Market in North America?

North America is the dominating region in the polymerase chain reaction (PCR) market. The strong market presence in North America is attributed to well-developed healthcare systems, which are characterized by high levels of research funding and access to advanced technologies. A strong understanding of PCR applications is often observed among the general public and healthcare professionals in North America, which is leading to greater demand for diagnostic tests and research tools. Strict guidelines for diagnostic tests and medical devices are enforced by regulatory bodies in North America. This emphasis on quality ensures accuracy and reliability, thereby driving market growth through the adoption of advanced PCR instruments and assays. As a result of these factors, North America's position as the dominant force in the PCR market is being solidified.

How does the Focus on Innovation Foster the Growth of the Polymerase Chain Reaction PCR Market in Europe?

Europe is the fastest-growing region in the polymerase chain reaction (PCR) market during the forecast period characterized by a mature market landscape where innovation is highly prioritized. A significant number of leading research institutions are housed in Europe, where heavy reliance on PCR for various applications in life sciences is observed. The advancement of PCR technology and the fostering of a dynamic market environment are being fueled by government support for research and development activities. A growing emphasis on personalized medicine is being witnessed across Europe, by which a demand for sophisticated PCR tools used in genetic analysis and tailored healthcare approaches is being created. These factors are collectively contributing to Europe's rapid growth in the PCR market, positioning it as a region where cutting-edge developments and increasing adoption of PCR technologies are being consistently observed.

Competitive Landscape

The Polymerase Chain Reaction PCR Market continues to change and evolve with innovations and also new technologies. There is a continuous promotion of new materials and the improvement of sensors. Cloud-based delivery by companies needs to meet new industry requirements and demands. The market share for polymerase chain reaction PCR is an intense and consistently evolving field where new and old players are still fighting for occupation.

Some of the key players operating in the polymerase chain reaction PCR market include:

Hoffmann-La Roche Ltd.

Thermo Fisher Scientific Inc.

Merck KGaA, Agilent Technologies, Inc.

Danaher Corporation

Bio-Rad Laboratories Inc.

QIAGEN N.V.

Abbott Laboratories

Takara Bio Inc.

Becton

Dickinson and Company

Polymerase Chain Reaction (PCR) Market Latest Developments

In October 2024, Abbott Laboratories announced that they got clearance for their Alinity mPCR System, a real-time PCR platform for clinical laboratories. This user-friendly, automated system aimed to expand PCR technology access for various diagnostic applications.

In May 2024, Thermo Fisher Scientific announced the launch of the Applied Biosystems TaqMan MiniChip PCR System, a miniaturized platform for point-of-care settings. This development addressed the market's growing interest in portable PCR solutions for rapid diagnostics in resource-limited environments.

1 INTRODUCTION OF GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT

5.1 Overview
5.2 Instruments
5.3 Reagents & Consumables

6 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION

6.1 Overview
6.2 Clinical Diagnostics
6.3 Life Sciences Cloud-based

7 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY END-USER

7.1 Overview
7.2 Clinical Diagnostics Labs
7.3 Research Institutions
7.4 Pharmaceutical Companies

8 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East & Africa

9 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Hoffmann-La Roche Ltd.
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Thermo Fisher Scientific Inc.
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Merck KGaA, Agilent Technologies, Inc.
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Danaher Corporation
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Bio-Rad Laboratories Inc.
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 QIAGEN N.V.
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Abbott Laboratories
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Takara Bio Inc.
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Becton
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Dickinson and Company
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments